Axonics Modulation Technologies

-$0.91 (-1.40%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXNX and other ETFs, options, and stocks.

About AXNX

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women.

CEO

Raymond Wayne Cohen

Employees

416

Headquarters

Irvine, California

Founded

2012

AXNX Key Statistics

Market Cap

2.91B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

446.96K

High Today

$65.40

Low Today

$63.42

Open Price

$64.73

Volume

247.44K

52 Week High

$68.20

52 Week Low

$34.00

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

AXNX Earnings

-$0.75

-$0.50

-$0.25

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 5, After Hours